{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:00:26Z","timestamp":1791644426717,"version":"4.3.4"},"reference-count":14,"publisher":"American Society for Microbiology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Clearance of<jats:named-content content-type=\"genus-species\">Histoplasma<\/jats:named-content>antigen has been used as a marker for response to treatment of progressive disseminated histoplasmosis (PDH) in patients with AIDS. Advancements in<jats:named-content content-type=\"genus-species\">Histoplasma<\/jats:named-content>antigen detection permit accurate quantification of antigen concentration. We compared the clearance of antigenemia and antigenuria during effective treatment of PDH. Urine and serum specimens were serially collected from patients with AIDS who were successfully treated for PDH as part of two prospective clinical trials. Samples were stored frozen until they were tested in the quantitative<jats:named-content content-type=\"genus-species\">Histoplasma<\/jats:named-content>antigen enzyme immunoassay. The kinetics of antigen clearance during the first 12 weeks of therapy were assessed in urine and serum during treatment with liposomal or deoxycholate amphotericin B followed by itraconazole and, in a separate analysis, in patients receiving only itraconazole. Latent class growth analysis was performed to define patterns of antigen clearance over time. In patients receiving amphotericin B, antigen levels declined the most during the first 2 weeks of treatment and antigenemia decreased more rapidly than antigenuria (5.90 ng\/ml per week versus 4.21 ng\/ml per week, respectively;<jats:italic>P<\/jats:italic>= 0.09). Mean reductions of antigen levels from baseline at weeks 2 and 12 were greater in sera than in urine: 11.26 ng\/ml versus 7.65 ng\/ml (<jats:italic>P<\/jats:italic>= 0.0948) and 18.52 ng\/ml versus 14.64 ng\/ml (<jats:italic>P<\/jats:italic>= 0.0440), respectively. In patients who received itraconazole alone, most of the decline in antigenuria occurred later during treatment and was overall slower than that seen with amphotericin B (<jats:italic>P<\/jats:italic>&lt; 0.0001). Results of latent class growth modeling showed two distinct trajectories for each parameter. With effective therapy,<jats:named-content content-type=\"genus-species\">Histoplasma<\/jats:named-content>antigenemia decreases more rapidly than antigenuria, providing a more sensitive early laboratory marker for response to treatment. Antigenuria declines earlier with amphotericin B than with itraconazole.<\/jats:p>","DOI":"10.1128\/cvi.00389-10","type":"journal-article","created":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T03:26:26Z","timestamp":1297308386000},"page":"661-666","source":"Crossref","is-referenced-by-count":76,"title":["Histoplasma Antigen Clearance during Treatment of Histoplasmosis in Patients with AIDS Determined by a Quantitative Antigen Enzyme Immunoassay"],"prefix":"10.1128","volume":"18","author":[{"given":"Chadi A.","family":"Hage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Stump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Kauffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Joseph","family":"Wheat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Baddley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2011,2,9]]},"reference":[{"key":"key20180919073509_B1","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1128\/CVI.00071-07","article-title":"Detection of histoplasma antigen by a quantitative enzyme immunoassay","volume":"14","author":"Connolly","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073509_B2","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/JCM.35.9.2252-2255.1997","article-title":"Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen","volume":"35","author":"Durkin","year":"1997","journal-title":"J. Clin. Microbiol"},{"key":"key20180919073509_B3","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/420749","article-title":"Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy","volume":"38","author":"Goldman","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"key20180919073509_B4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-137-2-200207160-00008","article-title":"Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS","volume":"137","author":"Johnson","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"key20180919073509_B5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ab.20215","article-title":"Multiple trajectories of physical aggression among adolescent boys and girls","volume":"34","author":"Martino","year":"2008","journal-title":"Aggress. Behav."},{"key":"key20180919073509_B6","article-title":"Mplus user's guide","author":"Muthen","year":"2004"},{"key":"key20180919073509_B7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0002-9343(99)80311-8","article-title":"Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group","volume":"98","author":"Wheat","year":"1995","journal-title":"Am. J. Med."},{"key":"key20180919073509_B8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1086\/313752","article-title":"Practice guidelines for the management of patients with histoplasmosis","volume":"30","author":"Wheat","year":"2000","journal-title":"Infectious Diseases Society of America. Clin. Infect. Dis."},{"key":"key20180919073509_B9","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1128\/AAC.45.8.2354-2357.2001","article-title":"Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole","volume":"45","author":"Wheat","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"key20180919073509_B10","doi-asserted-by":"crossref","first-page":"936","DOI":"10.7326\/0003-4819-115-12-936","article-title":"Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels","volume":"115","author":"Wheat","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"key20180919073509_B11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0002-9343(92)90106-L","article-title":"Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis","volume":"92","author":"Wheat","year":"1992","journal-title":"Am. J. Med."},{"key":"key20180919073509_B12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/AAC.46.1.248-250.2002","article-title":"Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS","volume":"46","author":"Wheat","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"key20180919073509_B13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America","volume":"45","author":"Wheat","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"key20180919073509_B14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13693780601185947","article-title":"Reduction in false antigenemia in the second generation Histoplasma antigen assay","volume":"45","author":"Wheat","year":"2007","journal-title":"Med. Mycol."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00389-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:44:52Z","timestamp":1627591492000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00389-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,9]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,6]]},"published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1128\/CVI.00389-10"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00389-10","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,9]]}}}